Spending Cuts can Prove to be Damaging for Healthcare in New Brunswick
Submitted by Ria Patel on Tue, 01/18/2011 - 16:02It has been warned by the New Brunswick Medical Society on the 18th of January that cuts being announced by the Government could have a damning effect on the quality of health care being provided in the province. It needs to be noted that the health care system is already tackling the problem of a shortage in doctors, nurses and other health care providers.
Huge Spending on Health in New Brunswick Proving Fruitless
Submitted by Jayden Roberts on Wed, 12/29/2010 - 16:18New Brunswick is facing the major troubles with its health systems sinking deep into the waters of millions but still producing no desirable results.
The expenditure being incurred on the health system of the city is rising at an alarming rate and is soon going to be unaffordable by the government, as per the sources.
Brunswick Health Minister Announces Aid for a Three Year Old Suffering from Cancer
Submitted by Amit Pathania on Fri, 03/27/2009 - 15:51New Brunswick's health minister Michael Murphy announced, on Thursday, that the province is going to fund the experimental treatment of a Cap-Pele boy suffering from cancer.
Super Women Need Help Too!
Submitted by Amit Pathania on Wed, 03/25/2009 - 15:38According to new figures, more and more women are seeking psychiatric help. According to experts the burden of earning, raising children, taking care of aging parents and all the rest that come with the changing times are driving women to the edge of nervous breakdown more than ever.
Marketing Lobsters is a Serious Business for Canada
Submitted by Harkamal Singh on Mon, 03/02/2009 - 08:35Who would have thought that marketing lobsters would become such serious business! Nevertheless, on Friday, federal and provincial ministers announced that government will spend nearly half a million dollars in joint funding on marketing Atlantic Canadian lobster.
Johnson & Johnson acquires Israel’s Omrix Biopharmaceuticals for $438 million
Submitted by Amit Pathania on Wed, 11/26/2008 - 00:57Johnson & Johnson (JNJ), US based pharmaceutical and FMCG major, has signed a deal to acquire Israel's Omrix Biopharmaceuticals (OMRI) for about $438 million in cash.












